Papilla Preservation Technique in Combination With Tooth Enamel Proteins and Animal Derived Bone Graft in Treating Isolated Bone Defects Between Teeth

September 9, 2025 updated by: Karthik Krishna M, Rungta College of Dental Sciences and Research

Evaluation of Entire Papilla Preservation Technique in Combination With Enamel Matrix Derivative & Bone Mineral Derived Xenograft in Isolated Interdental Intrabony Defects

The present three-arm study compared the clinical and tomographic efficacy of the Entire Papilla Preservation Surgical Technique (EPPT) alone and combined with enamel matrix derivative (EMD) plus bone mineral derivedxenograph (BMDX), in the treatment of isolated, inter-dental intra-bony defects.

Study Overview

Detailed Description

This randomized controlled clinical and tomographic study included 48 sites with isolated interdental intrabony defects, divided into three groups. Group 1 (control) received EPPT alone, Group 2 received EPPT with EMD, and Group 3 received EPPT with EMD and BMDX (Fix-Oss xenograft). Clinical parameters probing pocket depth (PPD), relative attachment level (RAL), gingival recession (GR), and papilla height-were recorded at baseline and 12 months. Cone-beam computed tomography (CBCT) was used to evaluate tomographic changes including defect width, CEJ-BD, CEJ-AC, X-ray INFRA and defect angle.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Chhattisgarh
      • Bhilai, Chhattisgarh, India, 490024
        • Rungta College of Dental Sciences and Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • stage II or III periodontitis, according to WWP 2017 classification of periodontal diseases in need of periodontal regenerative treatment for isolated intrabony defects
  • single-rooted teeth/multi-rooted teeth without furcation involvement

Exclusion Criteria:

  • uncontrolled or poorly controlled diabetes,
  • unstable or life-threatening conditions, or requiring antibiotic prophylaxis,
  • History of use of medications since last 6 months (immunosuppressants and antibiotics),
  • Subjects allergic to medications,
  • Pregnant or lactating women, Smokers/users of other tobacco products,
  • Subjects showing unacceptable oral hygiene maintenance after initial phase I therapy and
  • multiple interconnected vertical defects.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Entire Papilla Preservation Technique
Entire Papilla Preservation Technique alone
Entire Papilla Preservation Surgical Technique (EPPT) alone and combined with enamel matrix derivative (EMD) plus bone mineral derived xenograph (BMDX)
Active Comparator: Entire Papilla Preservation Technique with Emdogain
Entire Papilla Preservation Surgical Technique (EPPT) alone
Active Comparator: Entire Papilla Preservation Technique with Emdogain and Bovine Derived Xenograft
Entire Papilla Preservation Surgical Technique (EPPT) alone and combined with enamel matrix derivative (EMD)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
relative attachment level gain
Time Frame: 6 months
measuring relative attachment level gain with UNC-15 probe
6 months
pocket depth change
Time Frame: 6 months
measuring probing pocket depth changes
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tomographic defect width
Time Frame: 6 months
measured defect width in CBCT
6 months
the distance between the cemento-enamel junction and the bottom of the defect
Time Frame: 6 months
the distance between the cemento-enamel junction and the bottom of the defect
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2023

Primary Completion (Actual)

January 30, 2025

Study Completion (Actual)

March 30, 2025

Study Registration Dates

First Submitted

August 11, 2025

First Submitted That Met QC Criteria

August 11, 2025

First Posted (Actual)

August 13, 2025

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 9, 2025

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

For confidentiality

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Entire Papilla Preservation Technique

3
Subscribe